Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression
The 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) is a potential regulatory node in the mevalonate pathway that is frequently dysregulated in tumors. This study found that HMGCS1 expression is upregulated in stomach adenocarcinoma samples of patients and tumorspheres of gastric cancer cells. HM...
Main Authors: | I-Han Wang, Tzu-Ting Huang, Ji-Lin Chen, Li-Wei Chu, Yueh-Hsin Ping, Kai-Wen Hsu, Kuo-Hung Huang, Wen-Liang Fang, Hsin-Chen Lee, Chian-Feng Chen, Chen-Chung Liao, Rong-Hong Hsieh, Tien-Shun Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1088 |
Similar Items
-
Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis
by: Shaza Asif, et al.
Published: (2022-07-01) -
Ligustilide covalently binds to Cys129 of HMGCS1 to ameliorate dyslipidemia
by: Kaixue Zhang, et al.
Published: (2023-10-01) -
Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
by: Yuan-Hsi Wang, et al.
Published: (2020-07-01) -
Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis
by: Congcong Xu, et al.
Published: (2022-02-01) -
Pan‐cancer analysis reveals the oncogenic role of 3‐hydroxy‐3‐methylglutaryl‐CoA synthase 1
by: Cheng Zhou, et al.
Published: (2022-09-01)